Assessing 1-year sodium-glucose co-transporter-2 inhibitor tolerance in older adults
No clinically meaningful differences in SGLT2 inhibitor intolerance were observed in patients up to 84 years. Our findings support having closer follow-up when initiating in patients 85 years and older.
Authors
- Nancee V. Waterbury
- Marcia C Zeithamel
- Brian C Lund
- S. Schäfer
Institutions
- Louis Stokes Cleveland VA Medical Center (US)
- Iowa City VA Health Care System (US)
Publication Details
- Journal
- Age and Ageing
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/ageing/afae237
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72